And so it begins...

We all speculated that P&G signing the PDA for an extended 5 years would send a smoke signal to the rest of the other Global Partners, that P&G mean business to take one of OBJ's Technology Platform's (Non-Powered MicroArray) Global with their P&G stamp of approval via replicated Clinical Studies...twice...and this now appears to be the case with a very robust 4E with plenty of name-dropping which is an OBJ Management 'show of confidence' and very welcomed indeed:
















Coty & Personalised Skin Care are a little under the radar, but we know from previous announcements that Pers. Skin Care is under review from 2 FMCG's and Coty is taking their sweet time still.

All in all it is shaping up nicely with plenty of cash in the bank before Revenues by way of Royalties and Licensing Fees start pop up in the coming Quarterlies mostly from next year.  What will be the first company-maker to pop (product/partnership/upfront) and further re-rate OBJ's Share-price is anyone's guess as imo, it could come from anywhere !